Lenalidomide: A Review of Its Continuous Use in Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Stem-Cell Transplantation
Crossref DOI link: https://doi.org/10.1007/s40266-015-0269-6
Published Online: 2015-04-30
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
McCormack, Paul L.
Text and Data Mining valid from 2015-04-30
